newsfilter
← Latest News
PR Newswire·

CryoLife Receives CE Mark for E-nside Thoraco-abdominal Stent Graft

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received CE Mark...